| Year |
Citation |
Score |
| 2024 |
Krawic JR, Ladd NA, Cansler M, McMurtrey C, Devereaux J, Worley A, Ahmed T, Froyd C, Kulicke CA, Swarbrick G, Nilsen A, Lewinsohn DM, Adams EJ, Hildebrand W. Multiple Isomers of Photolumazine V Bind MR1 and Differentially Activate MAIT Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 38275935 DOI: 10.4049/jimmunol.2300609 |
0.681 |
|
| 2023 |
Nilsson JB, Kaabinejadian S, Yari H, Kester MGD, van Balen P, Hildebrand WH, Nielsen M. Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning. Science Advances. 9: eadj6367. PMID 38000035 DOI: 10.1126/sciadv.adj6367 |
0.416 |
|
| 2023 |
Nilsson JB, Kaabinejadian S, Yari H, Peters B, Barra C, Gragert L, Hildebrand W, Nielsen M. Machine learning reveals limited contribution of trans-only encoded variants to the HLA-DQ immunopeptidome. Communications Biology. 6: 442. PMID 37085710 DOI: 10.1038/s42003-023-04749-7 |
0.363 |
|
| 2022 |
Jin H, Ladd NA, Peev AM, Swarbrick GM, Cansler M, Null M, Boughter CT, McMurtrey C, Nilsen A, Dobos KM, Hildebrand WH, Lewinsohn DA, Adams EJ, Lewinsohn DM, Harriff MJ. Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells. Scientific Reports. 12: 22539. PMID 36581641 DOI: 10.1038/s41598-022-26259-y |
0.678 |
|
| 2022 |
Castro A, Kaabinejadian S, Yari H, Hildebrand W, Zanetti M, Carter H. Subcellular location of source proteins improves prediction of neoantigens for immunotherapy. The Embo Journal. e111071. PMID 36314681 DOI: 10.15252/embj.2022111071 |
0.402 |
|
| 2022 |
Kaabinejadian S, Barra C, Alvarez B, Yari H, Hildebrand WH, Nielsen M. Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome. Frontiers in Immunology. 13: 835454. PMID 35154160 DOI: 10.3389/fimmu.2022.835454 |
0.39 |
|
| 2020 |
Puig M, Ananthula S, Venna R, Kumar Polumuri S, Mattson E, Walker LM, Cardone M, Takahashi M, Su S, Boyd LF, Natarajan K, Abdoulaeva G, Wu WW, Roderiquez G, Hildebrand WH, et al. Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides. Frontiers in Immunology. 11: 629399. PMID 33633747 DOI: 10.3389/fimmu.2020.629399 |
0.457 |
|
| 2020 |
Reynisson B, Barra C, Kaabinejadian S, Hildebrand WH, Peters B, Nielsen M. Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data. Journal of Proteome Research. PMID 32308001 DOI: 10.1021/Acs.Jproteome.9B00874 |
0.445 |
|
| 2020 |
DeVette CI, Gundlapalli H, Lai SA, McMurtrey CP, Hoover AR, Gurung HR, Chen WR, Welm AL, Hildebrand WH. A pipeline for identification and validation of tumor-specific antigens in a mouse model of metastatic breast cancer. Oncoimmunology. 9: 1685300. PMID 32002300 DOI: 10.1080/2162402X.2019.1685300 |
0.733 |
|
| 2019 |
Tanno H, Gould TM, McDaniel JR, Cao W, Tanno Y, Durrett RE, Park D, Cate SJ, Hildebrand WH, Dekker CL, Tian L, Weyand CM, Georgiou G, Goronzy JJ. Determinants governing T cell receptor α/β-chain pairing in repertoire formation of identical twins. Proceedings of the National Academy of Sciences of the United States of America. PMID 31879353 DOI: 10.1073/Pnas.1915008117 |
0.317 |
|
| 2019 |
Kim C, Jadhav RR, Gustafson CE, Smithey MJ, Hirsch AJ, Uhrlaub JL, Hildebrand WH, Nikolich-Žugich J, Weyand CM, Goronzy JJ. Defects in Antiviral T Cell Responses Inflicted by Aging-Associated miR-181a Deficiency. Cell Reports. 29: 2202-2216.e5. PMID 31747595 DOI: 10.1016/J.Celrep.2019.10.044 |
0.323 |
|
| 2019 |
Linette GP, Becker-Hapak M, Skidmore ZL, Baroja ML, Xu C, Hundal J, Spencer DH, Fu W, Cummins C, Robnett M, Kaabinejadian S, Hildebrand WH, Magrini V, Demeter R, Krupnick AS, et al. Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens. Proceedings of the National Academy of Sciences of the United States of America. PMID 31685621 DOI: 10.1073/Pnas.1906026116 |
0.41 |
|
| 2019 |
Birrueta G, Frazier A, Pomés A, Glesner J, Filep S, Schal C, Jeong KY, McMurtrey C, Vander Schans T, Hildebrand WH, Busse P, Beigelman A, Bacharier LB, Peters B, Sette A, et al. Variability in German Cockroach Extract Composition Greatly Impacts T Cell Potency in Cockroach-Allergic Donors. Frontiers in Immunology. 10: 313. PMID 30891032 DOI: 10.3389/Fimmu.2019.00313 |
0.678 |
|
| 2019 |
DeVette C, Hoover A, Chen W, Hildebrand WH. P099 MHC class I laser immunotherapy for breast cancer Human Immunology. 80: 126. DOI: 10.1016/J.Humimm.2019.07.152 |
0.342 |
|
| 2019 |
Cate SJ, Gurung HR, Mwoyosvi M, Hildebrand WH. OR19 Crispr switching of HLA Class II phenotypes Human Immunology. 80: 25. DOI: 10.1016/J.Humimm.2019.07.021 |
0.402 |
|
| 2018 |
Harriff MJ, McMurtrey C, Froyd CA, Jin H, Cansler M, Null M, Worley A, Meermeier EW, Swarbrick G, Nilsen A, Lewinsohn DA, Hildebrand W, Adams EJ, Lewinsohn DM. MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage. Science Immunology. 3. PMID 30006464 DOI: 10.1126/Sciimmunol.Aao2556 |
0.687 |
|
| 2018 |
Hartmann N, Harriff MJ, McMurtrey CP, Hildebrand WH, Lewinsohn DM, Kronenberg M. Role of MAIT cells in pulmonary bacterial infection. Molecular Immunology. 101: 155-159. PMID 29940408 DOI: 10.1016/J.Molimm.2018.06.270 |
0.707 |
|
| 2018 |
da Silva Antunes R, Pham J, McMurtrey C, Hildebrand WH, Phillips E, Mallal S, Sidney J, Busse P, Peters B, Schulten V, Sette A. Urinary Peptides As a Novel Source of T Cell Allergen Epitopes. Frontiers in Immunology. 9: 886. PMID 29755469 DOI: 10.3389/Fimmu.2018.00886 |
0.742 |
|
| 2018 |
DeVette CI, Andreatta M, Bardet W, Cate SJ, Jurtz VI, Jackson KW, Welm AL, Nielsen M, Hildebrand WH. NetH2pan: A Computational Tool to Guide MHC peptide prediction on Murine Tumors. Cancer Immunology Research. PMID 29615400 DOI: 10.1158/2326-6066.Cir-17-0298 |
0.454 |
|
| 2018 |
Hartmann N, McMurtrey C, Sorensen ML, Huber ME, Kurapova R, Coleman FT, Mizgerd JP, Hildebrand W, Kronenberg M, Lewinsohn DM, Harriff MJ. Riboflavin Metabolism Variation Among Clinical Isolates of Streptococcus pneumoniae Results in Differential Activation of MAIT Cells. American Journal of Respiratory Cell and Molecular Biology. PMID 29356555 DOI: 10.1165/Rcmb.2017-0290Oc |
0.675 |
|
| 2018 |
Marty R, Kaabinejadian S, Rossel D, Slifker MJ, Haar JVd, Engin HB, Prisco Nd, Ideker T, Hildebrand WH, Font-Burgada J, Carter H. Abstract IA24: Are tumors predictable? Inherited immune variation constrains tumor evolution Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Aacriaslc18-Ia24 |
0.367 |
|
| 2017 |
Daga S, Moyse H, Briggs D, Lowe D, Evans N, Jones J, Buchli R, McMurtrey C, Mulder A, Hildebrand W, Claas F, Higgins R, Mitchell DA, Zehnder D. Response to the comments on "Direct quantitative measurement of the kinetics of HLA-specific antibody interactions with isolated HLA proteins". Human Immunology. PMID 29217367 DOI: 10.1016/J.Humimm.2017.12.001 |
0.718 |
|
| 2017 |
McMurtrey C, Harriff MJ, Swarbrick GM, Duncan A, Cansler M, Null M, Bardet W, Jackson KW, Lewinsohn DA, Hildebrand W, Lewinsohn DM. T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells. Plos One. 12: e0188288. PMID 29176828 DOI: 10.1371/Journal.Pone.0188288 |
0.772 |
|
| 2017 |
Daga S, Moyse H, Briggs D, Lowe D, Evans N, Jones J, Buchli R, McMurtrey C, Mulder A, Hildebrand W, Claas F, Higgins R, Mitchell DA, Zehnder D. Direct quantitative measurement of the kinetics of HLA-specific antibody interactions with isolated HLA proteins. Human Immunology. PMID 29097266 DOI: 10.1016/J.Humimm.2017.10.012 |
0.731 |
|
| 2017 |
Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, et al. Erratum: T cells from patients with Parkinson's disease recognize α-synuclein peptides. Nature. 549: 292. PMID 28905919 DOI: 10.1038/nature23896 |
0.687 |
|
| 2017 |
Dulberger CL, McMurtrey CP, Hölzemer A, Neu KE, Liu V, Steinbach AM, Garcia-Beltran WF, Sulak M, Jabri B, Lynch VJ, Altfeld M, Hildebrand WH, Adams EJ. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 46: 1018-1029.e7. PMID 28636952 DOI: 10.1016/J.Immuni.2017.06.002 |
0.757 |
|
| 2017 |
Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, et al. T cells from patients with Parkinson's disease recognize α-synuclein peptides. Nature. PMID 28636593 DOI: 10.1038/Nature22815 |
0.714 |
|
| 2017 |
Hilton HG, McMurtrey CP, Han AS, Djaoud Z, Guethlein LA, Blokhuis JH, Pugh JL, Goyos A, Horowitz A, Buchli R, Jackson KW, Bardet W, Bushnell DA, Robinson PJ, Mendoza JL, ... ... Hildebrand WH, et al. The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands. Cell Reports. 19: 1394-1405. PMID 28514659 DOI: 10.1016/J.Celrep.2017.04.059 |
0.758 |
|
| 2017 |
Remesh SG, Andreatta M, Ying G, Kaever T, Nielsen M, McMurtrey C, Hildebrand W, Peters B, Zajonc DM. Breaking confinement: unconventional peptide presentation by major histocompatibility (MHC) class I allele HLA-A*02:01. The Journal of Biological Chemistry. PMID 28179428 DOI: 10.1074/Jbc.M117.776542 |
0.768 |
|
| 2017 |
Remesh SG, Andreatta M, Ying G, Kaever T, Nielsen M, McMurtrey C, Hildebrand W, Peters B, Zajonc D. Unconventional peptide presentation by major histocompatibility class I allele HLA-A*02:01 Acta Crystallographica Section A. 73. DOI: 10.1107/S2053273317090520 |
0.569 |
|
| 2017 |
Buchli R, Buchli S, Henshaw E, Mata S, VanGundy R, Collard J, Judd E, Hildebrand WH, Smith JW. P098 Characterization and quantitation of soluble HLA molecules in human plasma Human Immunology. 78: 124. DOI: 10.1016/J.Humimm.2017.06.158 |
0.401 |
|
| 2017 |
Buchli R, Buchli S, Lowe D, VanGundy R, Collard J, Mulder A, Claas F, Duquesnoy R, Hildebrand WH. P075 Dose response features and parameters to consider in serological evaluation of transplant patients Human Immunology. 78: 108. DOI: 10.1016/J.Humimm.2017.06.135 |
0.41 |
|
| 2017 |
DeVette C, Can I, Ekiz A, Welm A, Hildebrand WH. O43 Therapeutic vaccination against breast cancer in a transgenic mouse model Human Immunology. 78: 40. DOI: 10.1016/J.Humimm.2017.06.049 |
0.438 |
|
| 2016 |
Greene JM, Dash P, Roy S, McMurtrey C, Awad W, Reed JS, Hammond KB, Abdulhaqq S, Wu HL, Burwitz BJ, Roth BF, Morrow DW, Ford JC, Xu G, Bae JY, ... ... Hildebrand W, et al. MR1-restricted mucosal-associated invariant T (MAIT) cells respond to mycobacterial vaccination and infection in nonhuman primates. Mucosal Immunology. PMID 27759023 DOI: 10.1038/Mi.2016.91 |
0.346 |
|
| 2016 |
Kaabinejadian S, McMurtrey CP, Kim S, Jain R, Bardet W, Schafer FB, Davenport JL, Martin AD, Diamond MS, Weidanz JA, Hansen TH, Hildebrand WH. Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late. Journal of Immunology (Baltimore, Md. : 1950). 196: 4263-73. PMID 27183642 DOI: 10.4049/Jimmunol.1501821 |
0.78 |
|
| 2016 |
Morozov GI, Zhao H, Mage MG, Boyd LF, Jiang J, Dolan MA, Venna R, Norcross MA, McMurtrey CP, Hildebrand W, Schuck P, Natarajan K, Margulies DH. Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing. Proceedings of the National Academy of Sciences of the United States of America. PMID 26869717 DOI: 10.1073/Pnas.1519894113 |
0.783 |
|
| 2016 |
McMurtrey C, Trolle T, Sansom T, Remesh SG, Kaever T, Bardet W, Jackson K, McLeod R, Sette A, Nielsen M, Zajonc DM, Blader IJ, Peters B, Hildebrand W. Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove. Elife. 5. PMID 26824387 DOI: 10.7554/Elife.12556 |
0.784 |
|
| 2016 |
Trolle T, McMurtrey CP, Sidney J, Bardet W, Osborn SC, Kaever T, Sette A, Hildebrand WH, Nielsen M, Peters B. The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference. Journal of Immunology (Baltimore, Md. : 1950). 196: 1480-7. PMID 26783342 DOI: 10.4049/Jimmunol.1501721 |
0.793 |
|
| 2016 |
McMurtrey C, Trolle T, Sansom T, Remesh SG, Kaever T, Bardet W, Jackson K, McLeod R, Sette A, Nielsen M, Zajonc DM, Blader IJ, Peters B, Hildebrand W. Author response: Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove Elife. DOI: 10.7554/Elife.12556.021 |
0.769 |
|
| 2016 |
DeVette C, Kaabinejadian S, Fujita M, Hildebrand W, Welm A. OR10 Tumor antigens presented by the HLA-A*02:01 of breast cancer patient-derived xenografts Human Immunology. 77: 9. DOI: 10.1016/J.Humimm.2016.07.022 |
0.487 |
|
| 2016 |
Kaabinejadian S, Buchli R, Swanson SJ, Gringeri AJ, Weidanz JA, Hildebrand WH. OR8 Quantitative assessment of HLA class I presentation in ICT-107, a dendritic cell-based immunotherapy Human Immunology. 77: 8. DOI: 10.1016/J.Humimm.2016.07.020 |
0.52 |
|
| 2016 |
McMurtrey C, Sjoelund V, Buchli R, Hildebrand W. OR1 Mapping anti-HLA antibody epitopes by painting the HLA blue Human Immunology. 77: 1. DOI: 10.1016/J.Humimm.2016.07.013 |
0.741 |
|
| 2015 |
Spencer CT, Bezbradica JS, Ramos MG, Arico CD, Conant SB, Gilchuk P, Gray JJ, Zheng M, Niu X, Hildebrand W, Link AJ, Joyce S. Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules. Proteomics. Clinical Applications. 9: 1035-52. PMID 26768311 DOI: 10.1002/Prca.201500106 |
0.52 |
|
| 2015 |
Patterson AM, Kaabinejadian S, McMurtrey CP, Bardet W, Jackson KW, Zuna RE, Husain S, Adams GP, MacDonald GC, Dillon RL, Ames H, Buchli R, Hawkins OE, Weidanz JA, Hildebrand WH. Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer. Molecular Cancer Therapeutics. PMID 26719579 DOI: 10.1158/1535-7163.Mct-15-0658 |
0.825 |
|
| 2015 |
Cram ED, Simmons RS, Palmer AL, Hildebrand WH, Rockey DD, Dolan BP. Enhanced direct MHC class I self-antigen presentation induced by Chlamydia infection. Infection and Immunity. PMID 26597986 DOI: 10.1128/Iai.01254-15 |
0.553 |
|
| 2015 |
Abelin JG, Trantham PD, Penny SA, Patterson AM, Ward ST, Hildebrand WH, Cobbold M, Bai DL, Shabanowitz J, Hunt DF. Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry. Nature Protocols. 10: 1308-18. PMID 26247297 DOI: 10.1038/Nprot.2015.086 |
0.445 |
|
| 2015 |
Carreno BM, Magrini V, Becker-Hapak M, Kaabinejadian S, Hundal J, Petti AA, Ly A, Lie WR, Hildebrand WH, Mardis ER, Linette GP. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science (New York, N.Y.). 348: 803-8. PMID 25837513 DOI: 10.1126/Science.Aaa3828 |
0.366 |
|
| 2015 |
Olvera A, Pérez-Álvarez S, Ibarrondo J, Ganoza C, Lama JR, Lucchetti A, Cate S, Hildebrand W, Bernard N, Gomez L, Sanchez J, Brander C. The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression. Aids (London, England). 29: 507-17. PMID 25715101 DOI: 10.1097/Qad.0000000000000574 |
0.388 |
|
| 2015 |
Olvera A, Ganoza C, Pérez-Álvarez S, Hildebrand W, Sanchez J, Brander C. HLA-B*35-PX and HLA-B*35-PY subtype differentiation does not predict observed differences in level of HIV control in a Peruvian MSM cohort. Aids (London, England). 28: 2323-5. PMID 25313587 DOI: 10.1097/Qad.0000000000000403 |
0.372 |
|
| 2015 |
Carreno BM, Magrini V, Becker-Hapak M, Kaabinejadian S, Hundal J, Petti AA, Ly A, Lie W, Hildebrand WH, Mardis ER, Linette GP. Abstract LB-237: Vaccination increases the breadth and diversity of melanoma neoantigen-specific T cells in humans Immunology. 75. DOI: 10.1158/1538-7445.Am2015-Lb-237 |
0.31 |
|
| 2015 |
Kaabinejadian S, McMurtrey C, Bardet W, Schafer F, Jackson K, Hildebrand W. West nile virus ligands from alternative reading frame proteins are revealed by class I HLA Human Immunology. 76: 152. DOI: 10.1016/J.Humimm.2015.07.211 |
0.577 |
|
| 2015 |
McMurtrey C, Bardet W, Osborn S, Jackson K, Schafer F, Hildebrand W. Comparison of HLA-A and HLA-B ligandomes Human Immunology. 76: 149. DOI: 10.1016/J.Humimm.2015.07.208 |
0.751 |
|
| 2015 |
Patterson AM, McMurtry C, Bardet W, Kaabinejadian S, Jackson K, Hildebrand W. OR36 Ligands distinct to ovarian cancer Hla-A*02:01 Human Immunology. 76: 31. DOI: 10.1016/J.Humimm.2015.07.042 |
0.543 |
|
| 2015 |
Yaciuk JC, Cate S, McMurtrey CP, Skaley M, Bardet W, Jackson KW, Hildebrand WH. OR8 HIV Infection leads to the presentation of unexpectedly long peptides by HLA-A*11:01 Human Immunology. 76: 20. DOI: 10.1016/J.Humimm.2015.07.028 |
0.74 |
|
| 2015 |
Kaabinejadian S, Patterson A, Bardet W, Jackson K, McMurtrey C, Wichner T, Hawkins O, Weidanz J, Hildebrand W. OR27 Monoclonal antibody RL41A recognizes cisplatin resistant ovarian cancer cells via HLA-A2 Human Immunology. 76: 11. DOI: 10.1016/J.Humimm.2015.07.019 |
0.791 |
|
| 2014 |
Yaciuk JC, Skaley M, Bardet W, Schafer F, Mojsilovic D, Cate S, Stewart CJ, McMurtrey C, Jackson KW, Buchli R, Olvera A, Cedeño S, Plana M, Mothe B, Brander C, ... ... Hildebrand WH, et al. Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells. Journal of Virology. 88: 12992-3004. PMID 25165114 DOI: 10.1128/Jvi.01914-14 |
0.764 |
|
| 2014 |
Piazza P, Campbell D, Marques E, Hildebrand WH, Buchli R, Mailliard R, Rinaldo CR. Dengue virus-infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes. Clinical and Experimental Immunology. 177: 696-702. PMID 24816171 DOI: 10.1111/Cei.12373 |
0.465 |
|
| 2014 |
Kim S, Pinto AK, Myers NB, Hawkins O, Doll K, Kaabinejadian S, Netland J, Bevan MJ, Weidanz JA, Hildebrand WH, Diamond MS, Hansen TH. A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice. European Journal of Immunology. 44: 1936-46. PMID 24723377 DOI: 10.1002/Eji.201444450 |
0.814 |
|
| 2014 |
May NA, Wang Q, Balbo A, Konrad SL, Buchli R, Hildebrand WH, Schuck P, Hudson AW. Human herpesvirus 7 U21 tetramerizes to associate with class I major histocompatibility complex molecules Journal of Virology. 88: 3298-3308. PMID 24390327 DOI: 10.1128/Jvi.02639-13 |
0.43 |
|
| 2014 |
McMurtrey C, Lowe D, Buchli R, Daga S, Royer D, Humphrey A, Cate S, Osborn S, Mojsilovic A, VanGundy R, Bardet W, Duty A, Mojsilovic D, Jackson K, Stastny P, ... ... Hildebrand W, et al. Profiling antibodies to class II HLA in transplant patient sera. Human Immunology. 75: 261-70. PMID 24269696 DOI: 10.1016/J.Humimm.2013.11.015 |
0.702 |
|
| 2014 |
Buchli R, Eggers R, Padilla GL, Mulder A, Jackson A, Tambur A, Claas F, Hildebrand W, Hogan M. The HLA protein chip: a high performance microarray platform for anti-HLA antibody detection utilizing soluble HLA F1000research. 5. DOI: 10.7490/F1000Research.1097245.1 |
0.44 |
|
| 2014 |
Patterson A, Bardet W, McMurtrey C, Kaabinejadian S, Jackson K, Hildebrand W. High-throughput characterization of the ovarian cancer HLA peptidome Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P139 |
0.753 |
|
| 2014 |
McMurtrey C, Harriff M, Liles L, Bardet W, Mojsilovic D, Jackson K, Schafer F, Swarbrick G, Lewinsohn D, Lewinsohn D, Hildebrand W. P093 Human Immunology. 75: 116. DOI: 10.1016/J.Humimm.2014.08.155 |
0.534 |
|
| 2014 |
Buchli R, Eggers R, Padilla GL, Mulder A, Jackson A, Tambur AR, Claas FHJ, Hildebrand WH, Hogan M. P084 : The Hla Protein Chip – A High Performance Microarray Platform For Anti-Hla Antibody Detection Utilizing Soluble Hla Human Immunology. 75: 109-109. DOI: 10.1016/J.Humimm.2014.08.146 |
0.43 |
|
| 2014 |
Buchli R, Mulder A, Jackson A, Tambur AR, Duquesnoy RJ, McAdams RD, Morris A, Eggers R, Padilla GL, Zehnder D, Lowe DP, Briggs DC, Higgins R, Claas FH, Hogan M, ... Hildebrand WH, et al. P083 Human Immunology. 75: 107-108. DOI: 10.1016/J.Humimm.2014.08.145 |
0.403 |
|
| 2014 |
Buchli R, Mulder A, Jackson A, Tambur AR, Duquesnoy RJ, McAdams RD, Eggers R, Padilla GL, Zehnder D, Lowe DP, Briggs DC, Higgins R, Claas FH, Hogan M, Hildebrand WH. P049 Human Immunology. 75: 84-85. DOI: 10.1016/J.Humimm.2014.08.111 |
0.415 |
|
| 2014 |
McMurtrey C, Bardet W, Jackson K, Blader I, Hildebrand W. OR55 Human Immunology. 75: 48. DOI: 10.1016/J.Humimm.2014.08.058 |
0.513 |
|
| 2014 |
McMurtrey C, Bardet W, Mojsilovic D, Jackson K, Liles L, Schafer F, Harriff M, Swarbrick G, Lewinsohn D, Lewinsohn D, Hildebrand W. OR16 Human Immunology. 75: 14. DOI: 10.1016/J.Humimm.2014.08.019 |
0.555 |
|
| 2014 |
McMurtrey C, Buchli R, Jackson K, Stewart C, Bardet W, Hildebrand W. OR14 Human Immunology. 75: 12. DOI: 10.1016/J.Humimm.2014.08.017 |
0.577 |
|
| 2013 |
Kaabinejadian S, Piazza PA, McMurtrey CP, Vernon SR, Cate SJ, Bardet W, Schafer FB, Jackson KW, Campbell DM, Buchli R, Rinaldo CR, Hildebrand WH. Identification of class I HLA T cell control epitopes for West Nile virus. Plos One. 8: e66298. PMID 23762485 DOI: 10.1371/Journal.Pone.0066298 |
0.787 |
|
| 2013 |
Gilchuk P, Spencer CT, Conant SB, Hill T, Gray JJ, Niu X, Zheng M, Erickson JJ, Boyd KL, McAfee KJ, Oseroff C, Hadrup SR, Bennink JR, Hildebrand W, Edwards KM, et al. Discovering naturally processed antigenic determinants that confer protective T cell immunity. The Journal of Clinical Investigation. 123: 1976-87. PMID 23543059 DOI: 10.1172/Jci67388 |
0.398 |
|
| 2013 |
Patterson A, Bardet W, Jackson K, Weidanz J, Hildebrand W. Direct analysis of HLA/HER-2 peptide epitopes Journal For Immunotherapy of Cancer. 1. DOI: 10.1186/2051-1426-1-S1-P62 |
0.591 |
|
| 2013 |
Buchli R, Mulder A, Duquesnoy RJ, McAdams RD, VanGundy RS, McMurtrey CP, Cate SJ, Zehnder D, Lowe DP, Briggs D, Higgins R, Claas FH, Hildebrand WH. 119-P Human Immunology. 74: 131. DOI: 10.1016/J.Humimm.2013.08.194 |
0.698 |
|
| 2013 |
Buchli R, Mulder A, Duquesnoy RJ, McAdams RD, VanGundy RS, McMurtrey CP, Cate SJ, Zehnder D, Lowe DP, Briggs D, Higgins R, Claas FH, Hildebrand WH. 118-P Human Immunology. 74: 131. DOI: 10.1016/J.Humimm.2013.08.193 |
0.705 |
|
| 2013 |
Daga S, McMurtrey C, Lowe D, Mitchell D, Briggs D, Hildebrand W, Higgins R, Zehnder D. 59-P Human Immunology. 74: 92. DOI: 10.1016/J.Humimm.2013.08.134 |
0.666 |
|
| 2013 |
Buchli R, Caseltine SL, McAdams RD, VanGundy RS, Wichner T, Rennels AD, Yaciuk JC, Duquesnoy RJ, Weidanz J, Hildebrand WH. 55-OR Human Immunology. 74: 44. DOI: 10.1016/J.Humimm.2013.08.066 |
0.325 |
|
| 2013 |
Yaciuk JC, Skaley M, McMurtrey CP, Cox D, Bardet W, Schafer F, Mojsilovic D, Stewart CJ, Cate S, Vernon S, Jackson K, Hildebrand WH. 29-OR Human Immunology. 74: 23. DOI: 10.1016/J.Humimm.2013.08.040 |
0.739 |
|
| 2013 |
Buchli R, McAdams R, Rennels AD, VanGundy RS, Hildebrand WH. 10-OR Human Immunology. 74: 10. DOI: 10.1016/J.Humimm.2013.08.021 |
0.539 |
|
| 2012 |
Li L, Kueppers F, Hildebrand W, Buchli R, Gaughan J. Elevated soluble HLA II protein levels in patients with alpha-1 antitrypsin deficiency with or without COPD. Experimental Lung Research. 38: 302-6. PMID 22686467 DOI: 10.3109/01902148.2012.691944 |
0.335 |
|
| 2012 |
Norcross MA, Luo S, Lu L, Boyne MT, Gomarteli M, Rennels AD, Woodcock J, Margulies DH, McMurtrey C, Vernon S, Hildebrand WH, Buchli R. Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity. Aids (London, England). 26: F21-9. PMID 22617051 DOI: 10.1097/Qad.0B013E328355Fe8F |
0.752 |
|
| 2012 |
Hoof I, van Baarle D, Hildebrand WH, Keşmir C. Proteome sampling by the HLA class I antigen processing pathway. Plos Computational Biology. 8: e1002517. PMID 22615552 DOI: 10.1371/Journal.Pcbi.1002517 |
0.526 |
|
| 2012 |
Sette A, Sidney J, Southwood S, Moore C, Berry J, Dow C, Bradley K, Hoof I, Lewis MG, Hildebrand WH, McMurtrey CP, Wilson NA, Watkins DI, Mothé BR. A shared MHC supertype motif emerges by convergent evolution in macaques and mice, but is totally absent in human MHC molecules. Immunogenetics. 64: 421-34. PMID 22322672 DOI: 10.1007/S00251-011-0598-5 |
0.773 |
|
| 2012 |
Buranapraditkun S, Hempel U, Hildebrand W, Allen T, Ruxrungtham K. The roles of HIV-1 specific CD8+ T cell responses and HLA class I alleles on viral control and viral escape in HIV-1 infected Thai individuals Retrovirology. 9: 248. DOI: 10.1186/1742-4690-9-S2-P248 |
0.404 |
|
| 2012 |
McMurtrey C, Lowe D, Buchli R, VanGundy R, Daga S, Cate S, Osborn S, Mojsilovic A, Bardet W, Duty JA, Stastny P, Briggs D, Zehnder D, Higgins RM, Hildebrand W. Removal and Recovery of Milligramme Quantities of HLA Antibodies from Human Sera Using HLA-DR11 Protein Affinity Chromatography Transplantation Journal. 94: 355. DOI: 10.1097/00007890-201211271-00658 |
0.445 |
|
| 2012 |
Hildebrand W, Weidanz J, Hansen T, Diamond M, McMurtrey C. Class I HLA presentation of west nile virus peptide epitopes Molecular Immunology. 51: 18. DOI: 10.1016/J.Molimm.2012.02.046 |
0.553 |
|
| 2012 |
Kaabinejadian S, Vernon SR, McMurtrey CP, Jackson LA, Bardet W, Mojsilovic D, Schafer FB, Jackson KW, Buchli R, Hildebrand WH. 184-P Human Immunology. 73: 164. DOI: 10.1016/J.Humimm.2012.07.310 |
0.802 |
|
| 2012 |
Eades MC, VanGundy RS, McAdams RD, McMurtrey CP, Cate SJ, Sigler SD, Rennels AD, Lira KM, Hildebrand WH, Buchli R. 81-P Human Immunology. 73: 103. DOI: 10.1016/J.Humimm.2012.07.207 |
0.433 |
|
| 2012 |
McMurtrey CP, Bardet W, Schafer F, Liles M, Toren K, Null M, Swarbrick G, Lewinsohn D, Lewinsohn D, Hildebrand W. 60-OR Human Immunology. 73: 47. DOI: 10.1016/J.Humimm.2012.07.140 |
0.769 |
|
| 2012 |
McMurtrey CP, Kim S, Jain R, Bardet W, Schafer F, Diamond MS, Weidanz J, Hansen T, Hildebrand W. 58-OR Human Immunology. 73: 46. DOI: 10.1016/J.Humimm.2012.07.090 |
0.776 |
|
| 2012 |
Skaley M, Cox D, Bardet W, McMurtrey C, Jackson K, Cate S, Mojsilovic A, Gumperz J, Hildebrand W. 53-OR Human Immunology. 73: 42. DOI: 10.1016/J.Humimm.2012.07.085 |
0.69 |
|
| 2012 |
Mojsilovic D, Jackson KW, Bardet W, Schafer F, Mojsilovic A, Osborn S, Watkins D, O’Connor D, Hildebrand WH. 37-Or: Class I Mhc Binding Motifs From Cynomolgus And Rhesus Macaques Human Immunology. 73: 31. DOI: 10.1016/J.Humimm.2012.07.069 |
0.594 |
|
| 2012 |
Yaciuk JC, Vernon SR, Bardet W, Schafer F, Skaley MS, Mojsilovic D, Mojsilovic A, Jackson KW, Hildebrand WH. 36-OR Human Immunology. 73: 31. DOI: 10.1016/J.Humimm.2012.07.068 |
0.457 |
|
| 2012 |
McMurtrey CP, Lowe D, Buchli R, Cate S, Osborn S, VanGundy R, Daga S, Bardet W, Mojsilovic A, Briggs D, Zehnder D, Higgins R, Hildebrand W. 34-OR Human Immunology. 73: 29. DOI: 10.1016/J.Humimm.2012.07.066 |
0.712 |
|
| 2012 |
Cate S, McMurtrey CP, Jackson K, Lowe D, Buchli R, VanGundy R, Osborn S, Mojsilovic A, Zehnder D, Hildebrand W. 31-OR Human Immunology. 73: 27. DOI: 10.1016/J.Humimm.2012.07.063 |
0.685 |
|
| 2012 |
VanGundy RS, McAdams RD, Lira KM, Eades MC, Cate SJ, McMurtrey CP, Sigler SD, Rennels AD, Hildebrand WH, Buchli R. 21-OR Human Immunology. 73: 18. DOI: 10.1016/J.Humimm.2012.07.053 |
0.396 |
|
| 2012 |
McMurtrey CP, Lowe D, Buchli R, VanGundy R, Daga S, Briggs D, Zehnder D, Higgins R, Hildebrand W. 16-OR Human Immunology. 73: 14. DOI: 10.1016/J.Humimm.2012.07.048 |
0.723 |
|
| 2012 |
VanGundy RS, Eades MC, McAdams RD, McMurtrey CP, Cate SJ, Lira KM, Sigler SD, Rennels AD, Hildebrand WH, Buchli R. 10-P Human Immunology. 73: 55. DOI: 10.1016/J.Humimm.2012.07.034 |
0.397 |
|
| 2012 |
McAdams RD, Lira KM, VanGundy RS, Eades MC, Sigler SD, Rennels AD, Hildebrand WH, Buchli R. 9-P Human Immunology. 73: 55. DOI: 10.1016/J.Humimm.2012.07.033 |
0.417 |
|
| 2012 |
Sigler SD, McAdams RD, Lira KM, VanGundy RS, Eades MC, Rennels AD, Hildebrand WH, Buchli R. 8-P Human Immunology. 73: 54. DOI: 10.1016/J.Humimm.2012.07.032 |
0.349 |
|
| 2012 |
Lira KM, McAdams RD, VanGundy RS, Eades MC, Sigler SD, Rennels AD, Hildebrand WH, Buchli R. 7-P Human Immunology. 73: 54. DOI: 10.1016/J.Humimm.2012.07.031 |
0.443 |
|
| 2011 |
Mothe B, Llano A, Ibarrondo J, Daniels M, Miranda C, Zamarreño J, Bach V, Zuniga R, Pérez-Ãlvarez S, Berger CT, Puertas MC, Martinez-Picado J, Rolland M, Farfan M, Szinger JJ, ... Hildebrand WH, et al. Definition of the viral targets of protective HIV-1-specific T cell responses. Journal of Translational Medicine. 9: 208. PMID 22152067 DOI: 10.1186/1479-5876-9-208 |
0.35 |
|
| 2011 |
Weidanz JA, Hawkins O, Verma B, Hildebrand WH. TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells. International Reviews of Immunology. 30: 328-40. PMID 22053972 DOI: 10.3109/08830185.2011.604880 |
0.825 |
|
| 2011 |
Weidanz JA, Hildebrand WH. Expanding the targets available to therapeutic antibodies via novel disease-specific markers. International Reviews of Immunology. 30: 312-27. PMID 22053971 DOI: 10.3109/08830185.2011.608136 |
0.51 |
|
| 2011 |
Buranapraditkun S, Hempel U, Pitakpolrat P, Allgaier RL, Thantivorasit P, Lorenzen SI, Sirivichayakul S, Hildebrand WH, Altfeld M, Brander C, Walker BD, Phanuphak P, Hansasuta P, Rowland-Jones SL, Allen TM, et al. A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais. Plos One. 6: e23603. PMID 21887282 DOI: 10.1371/Journal.Pone.0023603 |
0.331 |
|
| 2011 |
Greene JM, Wiseman RW, Lank SM, Bimber BN, Karl JA, Burwitz BJ, Lhost JJ, Hawkins OE, Kunstman KJ, Broman KW, Wolinsky SM, Hildebrand WH, O'Connor DH. Differential MHC class I expression in distinct leukocyte subsets. Bmc Immunology. 12: 39. PMID 21762519 DOI: 10.1186/1471-2172-12-39 |
0.791 |
|
| 2011 |
Reed JS, Sidney J, Piaskowski SM, Glidden CE, León EJ, Burwitz BJ, Kolar HL, Eernisse CM, Furlott JR, Maness NJ, Walsh AD, Rudersdorf RA, Bardet W, McMurtrey CP, O'Connor DH, ... Hildebrand WH, et al. The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection. Immunogenetics. 63: 789-807. PMID 21732180 DOI: 10.1007/S00251-011-0541-9 |
0.79 |
|
| 2011 |
Hawkins O, Verma B, Lightfoot S, Jain R, Rawat A, McNair S, Caseltine S, Mojsilovic A, Gupta P, Neethling F, Almanza O, Dooley W, Hildebrand W, Weidanz J. An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. Journal of Immunology (Baltimore, Md. : 1950). 186: 6607-16. PMID 21515791 DOI: 10.4049/Jimmunol.1003995 |
0.789 |
|
| 2011 |
Lyke KE, Fernández-Viňa MA, Cao K, Hollenbach J, Coulibaly D, Kone AK, Guindo A, Burdett LA, Hartzman RJ, Wahl AR, Hildebrand WH, Doumbo OK, Plowe CV, Sztein MB. Association of HLA alleles with Plasmodium falciparum severity in Malian children Tissue Antigens. 77: 562-571. PMID 21447146 DOI: 10.1111/J.1399-0039.2011.01661.X |
0.504 |
|
| 2011 |
Southwood S, Solomon C, Hoof I, Rudersdorf R, Sidney J, Peters B, Wahl A, Hawkins O, Hildebrand W, Mothé BR, Sette A. Functional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A1*02601 and Mamu-B*08301 reveals HLA-A2 and HLA-A3 supertypic specificities. Immunogenetics. 63: 275-90. PMID 21274527 DOI: 10.1007/S00251-010-0502-8 |
0.794 |
|
| 2011 |
Budde ML, Lhost JJ, Burwitz BJ, Becker EA, Burns CM, O'Connor SL, Karl JA, Wiseman RW, Bimber BN, Zhang GL, Hildebrand W, Brusic V, O'Connor DH. Transcriptionally abundant major histocompatibility complex class I alleles are fundamental to nonhuman primate simian immunodeficiency virus-specific CD8+ T cell responses. Journal of Virology. 85: 3250-61. PMID 21270169 DOI: 10.1128/Jvi.02355-10 |
0.434 |
|
| 2011 |
Gleimer M, Wahl AR, Hickman HD, Abi-Rached L, Norman PJ, Guethlein LA, Hammond JA, Draghi M, Adams EJ, Juo S, Jalili R, Gharizadeh B, Ronaghi M, Garcia KC, Hildebrand WH, et al. Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires. Journal of Immunology (Baltimore, Md. : 1950). 186: 1575-88. PMID 21209280 DOI: 10.4049/Jimmunol.1002990 |
0.45 |
|
| 2011 |
Zhang GL, O'Connor DH, Budde ML, Hildebrand WH, Lhost JJ, Brusic V. PRED mafa: A system for prediction of peptide binding to several MHC class i molecules in cynomolgus macaques 2011 Acm Conference On Bioinformatics, Computational Biology and Biomedicine, Bcb 2011. 602-606. DOI: 10.1145/2147805.2147908 |
0.41 |
|
| 2011 |
McMurtrey CP, Bade-Döding C, Bardet W, Jackson K, Vernon S, Rudersdorf R, Watkins D, Blasczyk R, Hildebrand W. 37-OR: MHC-E presents extended peptide ligands Human Immunology. 72: S180. DOI: 10.1016/J.Humimm.2011.07.282 |
0.742 |
|
| 2011 |
McMurtrey CP, Lowe D, Duty A, Cate S, Osborn S, Mojsilovic A, Higgins R, VanGundy R, Buchli R, Briggs D, Hildebrand W. 161-P Specific removal of antibodies to HLA-DRB1 from patient sera Human Immunology. 72: S121. DOI: 10.1016/J.Humimm.2011.07.186 |
0.705 |
|
| 2011 |
Lowe D, McMurtrey C, Zehnder D, Cate S, Higgins R, Buchli R, Mitchell D, VanGundy R, Hildebrand W, Briggs D. 156-P Specific removal of HLA class I directed antibodies from human sera Human Immunology. 72: S119. DOI: 10.1016/J.Humimm.2011.07.181 |
0.728 |
|
| 2011 |
Buchli R, Hildebrand W, Cate S. 12-P Soluble HLA coupled luminex beads Human Immunology. 72: S22. DOI: 10.1016/J.Humimm.2011.07.035 |
0.33 |
|
| 2010 |
Piazza P, McMurtrey CP, Lelic A, Cook RL, Hess R, Yablonsky E, Borowski L, Loeb MB, Bramson JL, Hildebrand WH, Rinaldo CR. Surface phenotype and functionality of WNV specific T cells differ with age and disease severity. Plos One. 5: e15343. PMID 21179445 DOI: 10.1371/Journal.Pone.0015343 |
0.71 |
|
| 2010 |
Augustine AD, Cassetti MC, Ennis FA, Harris E, Hildebrand WH, Repik PM. NIAID workshop on Flavivirus immunity. Viral Immunology. 23: 235-40. PMID 20565288 DOI: 10.1089/Vim.2009.0114 |
0.318 |
|
| 2010 |
Kim S, Li L, McMurtrey CP, Hildebrand WH, Weidanz JA, Gillanders WE, Diamond MS, Hansen TH. Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection. Journal of Immunology (Baltimore, Md. : 1950). 184: 4423-30. PMID 20212098 DOI: 10.4049/Jimmunol.0903955 |
0.762 |
|
| 2010 |
Verma B, Hawkins OE, Neethling FA, Caseltine SL, Largo SR, Hildebrand WH, Weidanz JA. Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties. Cancer Immunology, Immunotherapy : Cii. 59: 563-73. PMID 19779714 DOI: 10.1007/S00262-009-0774-8 |
0.798 |
|
| 2010 |
Wahl A, Schafer F, Bardet W, Hildebrand WH. HLA class I molecules reflect an altered host proteome after influenza virus infection. Human Immunology. 71: 14-22. PMID 19748539 DOI: 10.1016/J.Humimm.2009.08.012 |
0.488 |
|
| 2009 |
Fox LM, Cox DG, Lockridge JL, Wang X, Chen X, Scharf L, Trott DL, Ndonye RM, Veerapen N, Besra GS, Howell AR, Cook ME, Adams EJ, Hildebrand WH, Gumperz JE. Recognition of lyso-phospholipids by human natural killer T lymphocytes. Plos Biology. 7: e1000228. PMID 19859526 DOI: 10.1371/Journal.Pbio.1000228 |
0.4 |
|
| 2009 |
Wahl A, McCoy W, Schafer F, Bardet W, Buchli R, Fremont DH, Hildebrand WH. T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope. Journal of Virology. 83: 9206-14. PMID 19553306 DOI: 10.1128/Jvi.00932-09 |
0.458 |
|
| 2009 |
Loffredo JT, Sidney J, Bean AT, Beal DR, Bardet W, Wahl A, Hawkins OE, Piaskowski S, Wilson NA, Hildebrand WH, Watkins DI, Sette A. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. Journal of Immunology (Baltimore, Md. : 1950). 182: 7763-75. PMID 19494300 DOI: 10.4049/Jimmunol.0900111 |
0.811 |
|
| 2009 |
Cox D, Fox L, Tian R, Bardet W, Skaley M, Mojsilovic D, Gumperz J, Hildebrand W. Determination of Cellular Lipids Bound to Human CD1d Molecules Plos One. 4. PMID 19415116 DOI: 10.1371/Journal.Pone.0005325 |
0.335 |
|
| 2009 |
Burwitz BJ, Pendley CJ, Greene JM, Detmer AM, Lhost JJ, Karl JA, Piaskowski SM, Rudersdorf RA, Wallace LT, Bimber BN, Loffredo JT, Cox DG, Bardet W, Hildebrand W, Wiseman RW, et al. Mauritian cynomolgus macaques share two exceptionally common major histocompatibility complex class I alleles that restrict simian immunodeficiency virus-specific CD8+ T cells. Journal of Virology. 83: 6011-9. PMID 19339351 DOI: 10.1128/Jvi.00199-09 |
0.422 |
|
| 2009 |
Tuli A, Sharma M, Wang X, Simone LC, Capek HL, Cate S, Hildebrand WH, Naslavsky N, Caplan S, Solheim JC. Amyloid precursor-like protein 2 association with HLA class I molecules. Cancer Immunology, Immunotherapy : Cii. 58: 1419-31. PMID 19184004 DOI: 10.1007/S00262-009-0657-Z |
0.492 |
|
| 2009 |
Wahl A, Schafer F, Bardet W, Buchli R, Air GM, Hildebrand WH. HLA class I molecules consistently present internal influenza epitopes. Proceedings of the National Academy of Sciences of the United States of America. 106: 540-5. PMID 19122146 DOI: 10.1073/Pnas.0811271106 |
0.478 |
|
| 2009 |
Ibarrondo J, Zúñiga R, Farfán M, Suarez J, Mothe B, Llano A, Szinger JJ, Hildebrand W, Sánchez J, Korber BT, Brander C. P16-24. Crucial contribution of sub-dominant HLA-C allele restricted CTL responses to the control of HIV Retrovirology. 6: P253. DOI: 10.1186/1742-4690-6-S3-P253 |
0.34 |
|
| 2009 |
Hempel U, Buranapraditkun S, Chatkulkawin P, Pitakpolrat P, Phillips LC, Allgaier RL, Lorenzen S, Hildebrand WH, Leitner T, Matthews P, Goulder P, Walker BD, Ruxrungtham K, Allen TM. P16-07. HLA-B1302 is associated with viral control in clade CRF01_AE HIV-1 infection in Thailand Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P236 |
0.404 |
|
| 2009 |
Zuniga R, Mothe B, Llano A, Ibarrondo J, Daniels M, Farfan M, Suarez J, Szinger J, Hildebrand W, Lucchetti A, Heckerman D, Goulder P, Walker B, Sanchez J, Korber B, et al. S011-06 OA. HIV specific T cell responses and response patterns associated with viral control independent of classical non-progessor HLA class I alleles Retrovirology. 6: O3. DOI: 10.1186/1742-4690-6-S3-O3 |
0.416 |
|
| 2009 |
Skaley MS, Zang X, Bardet W, Fogle M, Hildebrand WH. 281-P: Purification and characterization of soluble HLA class II Human Immunology. 70: S153. DOI: 10.1016/J.Humimm.2009.09.314 |
0.413 |
|
| 2009 |
McMurtrey CP, Piazza P, Lelic A, Loeb M, Bramson J, Rinaldo C, Hildebrand W. Poster session278-P: Phenotype of memory T cells specific for HLA-A*0201 restricted immunodominant West Nile Virus epitopes Human Immunology. 70. DOI: 10.1016/J.Humimm.2009.09.311 |
0.398 |
|
| 2009 |
Hawkins O, Neethling F, Lightfoot S, May R, Blakey G, Dooley W, Weidanz J, Hildebrand W. 276-P: Monoclonal antibody specific for an ornithine decarboxylase peptide/HLA A*0201 complex confirms presentation of the peptide on primary breast tumor Human Immunology. 70: S150. DOI: 10.1016/J.Humimm.2009.09.309 |
0.794 |
|
| 2009 |
Gulati U, Schafer F, Wahl A, Buchli R, Hildebrand WH. 275-P: Antibodies specific for class I HLA and influenza Human Immunology. 70: S150. DOI: 10.1016/J.Humimm.2009.09.308 |
0.422 |
|
| 2009 |
Cate SJ, Popko J, Hildebrand WH. 205-P: HLA haplotype assignment software package Human Immunology. 70: S115. DOI: 10.1016/J.Humimm.2009.09.238 |
0.34 |
|
| 2009 |
Zang X, Eckerd A, Cate S, Buchli R, Hildebrand W. 194-P: Characterization of secreted single class II HLA-DR & -DQ molecules Human Immunology. 70: S109. DOI: 10.1016/J.Humimm.2009.09.227 |
0.429 |
|
| 2009 |
Wahl AR, Schafer F, Bardet W, Hildebrand WH. 5-OR: HLA-A*0201 displays an altered host peptidome following influenza A virus infection Human Immunology. 70: S2. DOI: 10.1016/J.Humimm.2009.09.014 |
0.316 |
|
| 2009 |
Tian R, Cox D, Mojsicovic D, Hawkins O, Watkins D, Hildebrand W. 2-OR: Cynomolgus macaque MHC class I molecules present HLA-A and HLA-B like peptides Human Immunology. 70: S1. DOI: 10.1016/J.Humimm.2009.09.011 |
0.821 |
|
| 2009 |
Tuli A, Sharma M, Wang X, Simone LC, Capek HL, Cate S, Hildebrand WH, Naslavsky N, Caplan S, Solheim JC. Erratum to: Amyloid precursor-like protein 2 association with HLA class I molecules Cancer Immunology, Immunotherapy. 59: 339-339. DOI: 10.1007/S00262-009-0777-5 |
0.43 |
|
| 2008 |
Parsons R, Lelic A, Hayes L, Carter A, Marshall L, Evelegh C, Drebot M, Andonova M, McMurtrey C, Hildebrand W, Loeb MB, Bramson JL. The memory T cell response to West Nile virus in symptomatic humans following natural infection is not influenced by age and is dominated by a restricted set of CD8+ T cell epitopes. Journal of Immunology (Baltimore, Md. : 1950). 181: 1563-72. PMID 18606712 DOI: 10.4049/Jimmunol.181.2.1563 |
0.72 |
|
| 2008 |
Hawkins OE, Vangundy RS, Eckerd AM, Bardet W, Buchli R, Weidanz JA, Hildebrand WH. Identification of breast cancer peptide epitopes presented by HLA-A*0201. Journal of Proteome Research. 7: 1445-57. PMID 18345606 DOI: 10.1021/Pr700761W |
0.812 |
|
| 2008 |
McMurtrey CP, Lelic A, Piazza P, Chakrabarti AK, Yablonsky EJ, Wahl A, Bardet W, Eckerd A, Cook RL, Hess R, Buchli R, Loeb M, Rinaldo CR, Bramson J, Hildebrand WH. Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes. Proceedings of the National Academy of Sciences of the United States of America. 105: 2981-6. PMID 18299564 DOI: 10.1073/Pnas.0711874105 |
0.794 |
|
| 2008 |
Hawkins O, VanGundy R, Eckerd A, Bardet W, Buchli R, Weidanz J, Hildebrand W. 34-OR: Cytotoxic T lymphocytes of breast cancer survivors recognize novel epitopes presented by the HLA-A*0201 Human Immunology. 69: S115. DOI: 10.1016/J.Humimm.2008.08.241 |
0.759 |
|
| 2008 |
Wahl AR, Schafer FB, Bardet W, Buchli R, Eckerd A, Air G, Hildebrand WH. 190-P: HLA B*0702 class I presentation and immune recognition of influenza epitopes Human Immunology. 69: S100. DOI: 10.1016/J.Humimm.2008.08.209 |
0.441 |
|
| 2008 |
Zang X, Mojsilovi D, Tian R, Cate S, Buchli R, Hildebrand W. 133-P: Characterization of cells expressing single class II HLA-DR & -DQ alleles Human Immunology. 69: S74. DOI: 10.1016/J.Humimm.2008.08.152 |
0.449 |
|
| 2007 |
Hurley CK, Fernandez-Vina M, Hildebrand WH, Noreen HJ, Trachtenberg E, Williams TM, Baxter-Lowe LA, Begovich AB, Petersdorf E, Selvakumar A, Stastny P, Hegland J, Hartzman RJ, Carston M, Gandham S, et al. A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. Human Immunology. 68: 30-40. PMID 17207710 DOI: 10.1016/J.Humimm.2006.09.004 |
0.448 |
|
| 2007 |
Wahl A, Weidanz J, Hildebrand W. Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells. Expert Review of Proteomics. 3: 641-52. PMID 17181478 DOI: 10.1586/14789450.3.6.641 |
0.607 |
|
| 2007 |
Weidanz JA, Piazza P, Hickman-Miller H, Woodburn D, Nguyen T, Wahl A, Neethling F, Chiriva-Internati M, Rinaldo CR, Hildebrand WH. Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes. Journal of Immunological Methods. 318: 47-58. PMID 17134715 DOI: 10.1016/J.Jim.2006.09.019 |
0.85 |
|
| 2007 |
Yu XG, Lichterfeld M, Chetty S, Williams KL, Mui SK, Miura T, Frahm N, Feeney ME, Tang Y, Pereyra F, Labute MX, Pfafferott K, Leslie A, Crawford H, Allgaier R, ... Hildebrand W, et al. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. Journal of Virology. 81: 1619-31. PMID 17121793 DOI: 10.1128/Jvi.01580-06 |
0.49 |
|
| 2007 |
Hurton L, Siddik RI, Singh H, Olivares S, Rabinovich B, Hildebrand W, Lee D, Champlin R, Shpall E, Fernandez-Vina M, Cooper L. Identifying NK-Cell Donors for Cell Therapy Based on Functional Phenotype. Blood. 110: 3271-3271. DOI: 10.1182/Blood.V110.11.3271.3271 |
0.434 |
|
| 2007 |
Wahl AR, Schafer FB, Bardet W, Buchli R, Fleshman A, Air G, Hildebrand WH. 176-P: Viral HLA class I ligands mark the surface of influenza infected cells Human Immunology. 68: S103. DOI: 10.1016/J.Humimm.2007.08.199 |
0.412 |
|
| 2007 |
Pesoa S, Maiers M, Lucas DP, Hildebrand W, Zachary A, Cano P, Fernandez-Vina MA. 174-P: A Bw4-associated epitope cross-reactive with some HLA-A alleles is defined by a residue oustide the segment 77-83 Human Immunology. 68: S102. DOI: 10.1016/J.Humimm.2007.08.197 |
0.387 |
|
| 2007 |
Fernandez-Vina M, Pesoa S, Sheldon S, Hildebrand W, Cano P. 77-P: A supertypic system of serologic epitopes on HLA-C molecules correlates with the KIR-ligand dimorphism Human Immunology. 68: S53. DOI: 10.1016/J.Humimm.2007.08.100 |
0.403 |
|
| 2007 |
Tian R, Wahl AR, Hawkins O, O’Connor D, Hildebrand WH. 15-OR: Endogenously loaded Cynomolgus – macaque MHC class I peptides Human Immunology. 68. DOI: 10.1016/J.Humimm.2007.08.021 |
0.794 |
|
| 2007 |
Hawkins OE, VanGundy RS, Bardet W, Fleshman A, Buchli R, Hildebrand WH. 12-OR: Analysis of breast cancer peptide epitopes presented by HLA-a*0201 Human Immunology. 68. DOI: 10.1016/J.Humimm.2007.08.018 |
0.788 |
|
| 2007 |
McMurtrey CP, Lelic A, Wahl A, Bardet W, Fleshman A, Buchli R, Loeb M, Bramson J, Hildebrand W. 11-OR: Interaction of HLA-a*0201 and west nile virus Human Immunology. 68. DOI: 10.1016/J.Humimm.2007.08.017 |
0.343 |
|
| 2006 |
Weidanz JA, Nguyen T, Woodburn T, Neethling FA, Chiriva-Internati M, Hildebrand WH, Lustgarten J. Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing. Journal of Immunology (Baltimore, Md. : 1950). 177: 5088-97. PMID 17015692 DOI: 10.4049/Jimmunol.177.8.5088 |
0.49 |
|
| 2006 |
Buchli R, Vangundy RS, Giberson CF, Hildebrand WH. Critical factors in the development of fluorescence polarization-based peptide binding assays: an equilibrium study monitoring specific peptide binding to soluble HLA-A*0201. Journal of Immunological Methods. 314: 38-53. PMID 16844138 DOI: 10.1016/J.Jim.2006.05.010 |
0.506 |
|
| 2006 |
Honeyborne I, Rathod A, Buchli R, Ramduth D, Moodley E, Rathnavalu P, Chetty S, Day C, Brander C, Hildebrand W, Walker BD, Kiepiela P, Goulder PJ. Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern Africa. Journal of Immunology (Baltimore, Md. : 1950). 176: 4699-705. PMID 16585563 DOI: 10.4049/Jimmunol.176.8.4699 |
0.513 |
|
| 2006 |
Zuñiga R, Lucchetti A, Galvan P, Sanchez S, Sanchez C, Hernandez A, Sanchez H, Frahm N, Linde CH, Hewitt HS, Hildebrand W, Altfeld M, Allen TM, Walker BD, Korber BT, et al. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. Journal of Virology. 80: 3122-5. PMID 16501126 DOI: 10.1128/Jvi.80.6.3122-3125.2006 |
0.355 |
|
| 2006 |
McMurtrey CP, Bardet W, Fleshman A, Mason C, Wahl A, Jackson K, Hildebrand W. 55-OR: Direct discovery of class I HLA West Nile Virus epitopes Human Immunology. 67. DOI: 10.1016/J.Humimm.2006.08.067 |
0.737 |
|
| 2006 |
Tian R, Wahl AR, Hawkins O, Bardet W, O’Connor D, Hildebrand WH. 48-OR: Characterization of endogenously loaded Cynomolgus macaque MHC class I peptides Human Immunology. 67. DOI: 10.1016/J.Humimm.2006.08.058 |
0.796 |
|
| 2005 |
Loffredo JT, Sidney J, Piaskowski S, Szymanski A, Furlott J, Rudersdorf R, Reed J, Peters B, Hickman-Miller HD, Bardet W, Rehrauer WM, O'Connor DH, Wilson NA, Hildebrand WH, Sette A, et al. The high frequency Indian rhesus macaque MHC class I molecule, Mamu-B*01, does not appear to be involved in CD8+ T lymphocyte responses to SIVmac239. Journal of Immunology (Baltimore, Md. : 1950). 175: 5986-97. PMID 16237093 DOI: 10.4049/Jimmunol.175.9.5986 |
0.853 |
|
| 2005 |
Ellis NM, Li Y, Hildebrand W, Fischetti VA, Cunningham MW. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. Journal of Immunology (Baltimore, Md. : 1950). 175: 5448-56. PMID 16210652 DOI: 10.4049/Jimmunol.175.8.5448 |
0.383 |
|
| 2005 |
Buchli R, VanGundy RS, Hickman-Miller HD, Giberson CF, Bardet W, Hildebrand WH. Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery. Biochemistry. 44: 12491-507. PMID 16156661 DOI: 10.1021/Bi050255V |
0.843 |
|
| 2005 |
Hickman-Miller HD, Bardet W, Gilb A, Luis AD, Jackson KW, Watkins DI, Hildebrand WH. Rhesus macaque MHC class I molecules present HLA-B-like peptides. Journal of Immunology (Baltimore, Md. : 1950). 175: 367-75. PMID 15972670 DOI: 10.4049/Jimmunol.175.1.367 |
0.82 |
|
| 2005 |
Huang XL, Fan Z, Colleton BA, Buchli R, Li H, Hildebrand WH, Rinaldo CR. Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons. Journal of Virology. 79: 3052-62. PMID 15709025 DOI: 10.1128/Jvi.79.5.3052-3062.2005 |
0.475 |
|
| 2005 |
Petersen JL, Hickman-Miller HD, McIlhaney MM, Vargas SE, Purcell AW, Hildebrand WH, Solheim JC. A charged amino acid residue in the transmembrane/cytoplasmic region of tapasin influences MHC class I assembly and maturation. Journal of Immunology (Baltimore, Md. : 1950). 174: 962-9. PMID 15634919 DOI: 10.4049/Jimmunol.174.2.962 |
0.844 |
|
| 2005 |
Tian R, Cate S, Jones M, Hildebrand W. High resolution HLA typing for vaccine and autoimmune studies Human Immunology. 66: 125. DOI: 10.1016/J.Humimm.2005.08.236 |
0.306 |
|
| 2005 |
Hawkins O, Gonzalez M, Gilb A, Potapova T, Hildebrand W. MHC class I peptide analysis from a breast cancer cell line transfected with sHLA Human Immunology. 66: 117. DOI: 10.1016/J.Humimm.2005.08.223 |
0.799 |
|
| 2005 |
Cate S, Tian R, Roberts M, Hildebrand W. Novel ambiguity resolution for HLA SBT methods Human Immunology. 66: 31. DOI: 10.1016/J.Humimm.2005.08.055 |
0.365 |
|
| 2004 |
Buchli R, VanGundy RS, Hickman-Miller HD, Giberson CF, Bardet W, Hildebrand WH. Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization. Biochemistry. 43: 14852-63. PMID 15544356 DOI: 10.1021/Bi048580Q |
0.853 |
|
| 2004 |
Hickman-Miller HD, Hildebrand WH. The immune response under stress: the role of HSP-derived peptides. Trends in Immunology. 25: 427-33. PMID 15275642 DOI: 10.1016/J.It.2004.05.011 |
0.839 |
|
| 2004 |
Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M, Hurley C, Kollman C, Anasetti C, Noreen H, Begovich A, Hildebrand W, Petersdorf E, Schmeckpeper B, Setterholm M, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 104: 1923-30. PMID 15191952 DOI: 10.1182/Blood-2004-03-0803 |
0.38 |
|
| 2004 |
Ellerhorst JA, Hildebrand WH, Cavett JW, Fernandez-Vina MA, Hodges S, Poindexter N, Fischer H, Grimm EA. HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC. Der Urologe. Ausg. A. 43: S137. PMID 15148575 DOI: 10.1007/S00120-004-0603-9 |
0.371 |
|
| 2004 |
Hickman HD, Luis AD, Buchli R, Few SR, Sathiamurthy M, VanGundy RS, Giberson CF, Hildebrand WH. Toward a definition of self: proteomic evaluation of the class I peptide repertoire. Journal of Immunology (Baltimore, Md. : 1950). 172: 2944-52. PMID 14978097 DOI: 10.4049/Jimmunol.172.5.2944 |
0.54 |
|
| 2004 |
Leffell MS, Fallin MD, Hildebrand WH, Cavett JW, Iglehart BA, Zachary AA. HLA alleles and haplotypes among the Lakota Sioux: report of the ASHI minority workshops, part III. Human Immunology. 65: 78-89. PMID 14700599 DOI: 10.1016/J.Humimm.2003.10.001 |
0.382 |
|
| 2003 |
Hickman HD, Luis AD, Bardet W, Buchli R, Battson CL, Shearer MH, Jackson KW, Kennedy RC, Hildebrand WH. Cutting edge: class I presentation of host peptides following HIV infection. Journal of Immunology (Baltimore, Md. : 1950). 171: 22-6. PMID 12816978 DOI: 10.4049/Jimmunol.171.1.22 |
0.529 |
|
| 2003 |
Ellerhorst JA, Hildebrand WH, Cavett JW, Fernandez-Vina MA, Hodges S, Poindexter N, Fischer H, Grimm EA. Heterozygosity or homozygosity for 2 HLA class II haplotypes predict favorable outcomes for renal cell carcinoma treated with cytokine therapy. The Journal of Urology. 169: 2084-8. PMID 12771724 DOI: 10.1097/01.Ju.0000065810.80617.F4 |
0.343 |
|
| 2003 |
Sathiamurthy M, Hickman HD, Cavett JW, Zahoor A, Prilliman K, Metcalf S, Fernandez Vina MA, Hildebrand WH. Population of the HLA ligand database Tissue Antigens. 61: 12-19. PMID 12622773 DOI: 10.1034/J.1399-0039.2003.610102.X |
0.526 |
|
| 2003 |
Huang XL, Fan Z, Zheng L, Borowski L, Li H, Thomas EK, Hildebrand WH, Zhao XQ, Rinaldo CR. Priming of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteins. The Journal of Infectious Diseases. 187: 315-9. PMID 12552458 DOI: 10.1086/346054 |
0.329 |
|
| 2003 |
Tian R, Cavett J, Bennett T, Cate S, Jones M, Bardet W, Luis A, Hildebrand W. HLA-A∗02 polymorphism at amino acid 116 Human Immunology. 64: S160. DOI: 10.1016/J.Humimm.2003.08.304 |
0.329 |
|
| 2003 |
Bardet W, Hickman HD, Luis AD, Hildebrand WH. Production and purification of soluble class I molecules using a VLDL-receptor tag Human Immunology. 64: S120. DOI: 10.1016/J.Humimm.2003.08.225 |
0.326 |
|
| 2003 |
Sathiamurthy M, Hickman HD, Cavett JW, Hildebrand WH. Analyses of entries in the HLA ligand/motif database and the predictive algorithms empowered by these data Human Immunology. 64: S74. DOI: 10.1016/J.Humimm.2003.08.133 |
0.312 |
|
| 2003 |
Araujo HA, Spellman S, Cullen R, Mulder A, Burdett L, Kariyawasam K, Baxter-Lowe LA, Williams T, Hildebrand W, Ng J, Hurley CK, Hartzman R, Fernandez-Vina MA. HLA null and low expression alleles in the national marrow donor program® donor/recipient pair project Human Immunology. 64: S58. DOI: 10.1016/J.Humimm.2003.08.103 |
0.329 |
|
| 2003 |
Luis AD, Hickman HD, Bardet W, Hildebrand WH. Evaluation of mhc class I peptide-source proteins using Western blots and real-time PCR Human Immunology. 64: S23. DOI: 10.1016/J.Humimm.2003.08.040 |
0.473 |
|
| 2003 |
Hickman HD, Luis AD, Bardet W, Hildebrand WH. Host-derived peptides are uniquely presented by MHC class I molecules during HIV infection Human Immunology. 64: S24. DOI: 10.1016/J.Humimm.2003.08.003 |
0.483 |
|
| 2002 |
Vogel TU, Friedrich TC, O'Connor DH, Rehrauer W, Dodds EJ, Hickman H, Hildebrand W, Sidney J, Sette A, Hughes A, Horton H, Vielhuber K, Rudersdorf R, De Souza IP, Reynolds MR, et al. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence? Journal of Virology. 76: 11623-36. PMID 12388723 DOI: 10.1128/Jvi.76.22.11623-11636.2002 |
0.5 |
|
| 2002 |
Leffell MS, Fallin MD, Erlich HA, Fernandez-Vĩna M, Hildebrand WH, Mack SJ, Zachary AA. HLA antigens, alleles and haplotypes among the Yup'ik Alaska natives: report of the ASHI Minority Workshops, Part II. Human Immunology. 63: 614-25. PMID 12072196 DOI: 10.1016/S0198-8859(02)00415-9 |
0.422 |
|
| 2002 |
Hildebrand WH, Turnquist HR, Prilliman KR, Hickman HD, Schenk EL, McIlhaney MM, Solheim JC. HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction. Human Immunology. 63: 248-55. PMID 12039406 DOI: 10.1016/S0198-8859(02)00364-6 |
0.556 |
|
| 2002 |
Wang QJ, Huang XL, Rappocciolo G, Jenkins FJ, Hildebrand WH, Fan Z, Thomas EK, Rinaldo CR. Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8. Blood. 99: 3360-6. PMID 11964304 DOI: 10.1182/Blood.V99.9.3360 |
0.534 |
|
| 2002 |
Turnquist HR, Schenk EL, McIlhaney MM, Hickman HD, Hildebrand WH, Solheim JC. Disparate binding of chaperone proteins by HLA-A subtypes. Immunogenetics. 53: 830-4. PMID 11862383 DOI: 10.1007/S00251-001-0404-X |
0.418 |
|
| 2002 |
Cavett JW, Sidebottom D, Khamphanthala TT, Ellexson-Turner ME, Hickman HD, Jones MM, Cate SJ, Cupps SL, Hildebrand WH. Sequencing the HLA class II DQA locus Human Immunology. 63. DOI: 10.1016/S0198-8859(02)00674-2 |
0.41 |
|
| 2002 |
Luis AD, Hickman HD, Ellexson-Turner ME, Bardet W, Hildebrand WH. Analysis of MHC class I peptides bound in human herpesvirus 7-infected cells Human Immunology. 63: S62. DOI: 10.1016/S0198-8859(02)00588-8 |
0.552 |
|
| 2002 |
Hickman HD, Ellexson-Turner ME, Luis AD, Bardet W, Jackson KW, Hildebrand WH. MHC class I peptide characterization from HIV-infected cells Human Immunology. 63: S34. DOI: 10.1016/S0198-8859(02)00536-0 |
0.5 |
|
| 2001 |
Wu S, Shiao YM, Lai SM, Lai CY, Chen SP, Chen YF, Sidebottom DA, Hildebrand WH, Chou FC, Tsai MF. New DR5 sequences: a novel DRB1*11122 allele identified in Paiwan tribe members of Taiwan and a corrected sequence for the DRB1*1201 allele. Tissue Antigens. 58: 193-7. PMID 11703830 DOI: 10.1034/J.1399-0039.2001.580310.X |
0.413 |
|
| 2001 |
Ellexson-Turner ME, Leffell MS, Zachary AA, Turner S, Bennett T, Sidebottom DA, Cao K, Fernández-Viña M, Hildebrand WH. Sequence-based typing of HLA class I alleles in Alaskan Yupik Eskimo Human Immunology. 62: 639-644. PMID 11390039 DOI: 10.1016/S0198-8859(01)00243-9 |
0.414 |
|
| 2001 |
Wu S, Shiao YM, Lai CY, Lai SM, Chen SP, Sidebottom DA, Hildebrand WH, Tilanus MGJ, Chou FC, Tsai MF. Polymorphism of human HLA-DRB1 antigens generated by genetic exchange between DR2 (DRB1*15011) and DR6 (DRB1*1405) alleles: A novel DRB1 allele (DRB1*1437) identified in a Paiwan tribe member of Taiwan Tissue Antigens. 57: 384-387. PMID 11380954 DOI: 10.1034/J.1399-0039.2001.057004384.X |
0.4 |
|
| 2001 |
Hickman HD, Cavett JW, Ellexson-Turner ME, Sparkman JN, Bennett TT, Turner S, Sidebottom DA, Trachtenberg EA, Confer DL, Hildebrand WH. Non-conservative substitutions distinguish previously uncharacterized HLA-A molecules Tissue Antigens. 57: 95-102. PMID 11260503 DOI: 10.1034/J.1399-0039.2001.057002095.X |
0.434 |
|
| 2001 |
Sidebottom DA, Kennedy R, Hildebrand WH. Class I MHC expression in the yellow baboon Journal of Immunology. 166: 3983-3993. PMID 11238644 DOI: 10.4049/Jimmunol.166.6.3983 |
0.483 |
|
| 2001 |
Urvater JA, Hickman H, Dzuris JL, Prilliman K, Allen TM, Schwartz KJ, Lorentzen D, Shufflebotham C, Collins EJ, Neiffer DL, Raphael B, Hildebrand W, Sette A, Watkins DI. Gorillas with spondyloarthropathies express an MHC class I molecule with only limited sequence similarity to HLA-B27 that binds peptides with arginine at P2 Journal of Immunology. 166: 3334-3344. PMID 11207289 DOI: 10.4049/Jimmunol.166.5.3334 |
0.549 |
|
| 2001 |
Ellexson-Turner M, Sidebottom D, Turner S, Bennett T, Hildebrand WH. Precision genotyping of human leukocyte antigen-A, -B and -C loci via direct DNA sequencing Methods in Molecular Biology (Clifton, N.J.). 156: 129-142. PMID 11068755 DOI: 10.1385/1-59259-062-4:129 |
0.33 |
|
| 2001 |
Hickman HD, Shearer MH, Sparkman JN, Battson CL, Jackson KW, Kennedy RC, Hildebrand WH. Pathogen-derived MHC class I ligand identification in HIV-1 infected cells European Journal of Immunogenetics. 28: 220. |
0.471 |
|
| 2000 |
Hickman HD, Batson CL, Prilliman KR, Crawford DL, Jackson KL, Hildebrand WH. C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I positive cells. Human Immunology. 61: 1339-46. PMID 11163091 DOI: 10.1016/S0198-8859(00)00216-0 |
0.595 |
|
| 2000 |
Turnquist HR, Thomas HJ, Prilliman KR, Lutz CT, Hildebrand WH, Solheim JC. HLA-B polymorphism affects interactions with multiple endoplasmic reticulum proteins. European Journal of Immunology. 30: 3021-8. PMID 11069086 DOI: 10.1002/1521-4141(200010)30:10<3021::Aid-Immu3021>3.0.Co;2-U |
0.389 |
|
| 2000 |
Rinaldo CR, Huang XL, Fan Z, Margolick JB, Borowski L, Hoji A, Kalinyak C, Mcmahon DK, Riddler SA, Hildebrand WH, Day RB, Mellors JW. Anti-human immunodeficiency virus type 1 (HIV-1) CD8+ T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency Journal of Virology. 74: 4127-4138. PMID 10756025 DOI: 10.1128/Jvi.74.9.4127-4138.2000 |
0.341 |
|
| 1999 |
Prilliman KR, Crawford D, Hickman HD, Jackson KW, Wang J, Hildebrand WH. Alpha-2 domain polymorphism and HLA class I peptide loading. Tissue Antigens. 54: 450-60. PMID 10599884 DOI: 10.1034/J.1399-0039.1999.540502.X |
0.464 |
|
| 1999 |
Prilliman KR, Jackson KW, Lindsey M, Wang J, Crawford D, Hildebrand WH. HLA-B15 peptide ligands are preferentially anchored at their C termini. Journal of Immunology (Baltimore, Md. : 1950). 162: 7277-84. PMID 10358176 |
0.387 |
|
| 1999 |
Prilliman KR, Lindsey M, Wang J, Jackson KW, Hildebrand WH. Peptide motif of the class I molecule HLA-B*1503 Immunogenetics. 49: 144-146. PMID 9887352 DOI: 10.1007/S002510050474 |
0.561 |
|
| 1998 |
Turner S, Ellexson ME, Hickman HD, Sidebottom DA, Fernández-Viña M, Confer DL, Hildebrand WH. Sequence-based typing provides a new look at HLA-C diversity Journal of Immunology. 161: 1406-1413. PMID 9686604 |
0.315 |
|
| 1998 |
Ellexson ME, Peck RL, Stewart D, Keller J, Hildebrand WH. Characterization of an HLA-A26 serologic variant Immunogenetics. 48: 152-155. PMID 9634481 DOI: 10.1007/S002510050417 |
0.357 |
|
| 1998 |
Prilliman KR, Lindsey M, Jackson KW, Cole J, Bonner R, Hildebrand WH. Complexity among constituents of the HLA-B*1501 peptide motif Immunogenetics. 48: 89-97. PMID 9634472 DOI: 10.1007/S002510050408 |
0.546 |
|
| 1997 |
Ellexson M, Lai-Kwan P, Lau M, Muto K, Terasaki P, Cole J, Thompson C, Hildebrand W. Polymorphism at codons 114, 116, 145, and 163 muddle the typing of HLA-B*1304. Human Immunology. 55: 66-73. PMID 9328792 DOI: 10.1016/S0198-8859(97)00055-4 |
0.374 |
|
| 1997 |
Prilliman K, Lindsey M, Zuo Y, Jackson KW, Zhang Y, Hildebrand W. Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501. Immunogenetics. 45: 379-85. PMID 9089095 DOI: 10.1007/S002510050219 |
0.583 |
|
| 1997 |
Prilliman K, Steiner N, Ellexson M, Stewart D, Lau M, Terasaki P, Hurley C, Hildebrand W. Novel alleles HLA-B*7802 and B*51022: evidence for convergency in the HLA-B5 family. Tissue Antigens. 47: 49-57. PMID 8929712 DOI: 10.1111/J.1399-0039.1996.Tb02513.X |
0.323 |
|
| 1997 |
Ellexson M, Stewart D, Chrétien P, Zhang L, Hildebrand W. Description of a modified sequencing strategy and the molecular characterization of HLA-B*8201. Tissue Antigens. 47: 438-41. PMID 8795148 DOI: 10.1111/J.1399-0039.1996.Tb02583.X |
0.371 |
|
| 1996 |
Ellexson M, Lau M, Terasaki P, Hildebrand W. Molecular characterization of HLA-A*6803. Immunogenetics. 45: 78-9. PMID 8881043 DOI: 10.1007/S002510050172 |
0.416 |
|
| 1996 |
Chandanayingyong D, Adams EJ, Arnett KL, Hildebrand WH, Parham P, Lau M. The presence of HLA-A*2403 and HLA-B*1512 on the same haplotype in a Thai family. Tissue Antigens. 47: 426-7. PMID 8795144 DOI: 10.1111/J.1399-0039.1996.Tb02579.X |
0.413 |
|
| 1996 |
Prilliman K, Lawlor D, Ellexson M, McElwee N, Confer D, Cooper DK, Kennedy RC, Hildebrand W. Characterization of baboon class I major histocompatibility molecules. Implications for baboon-to-human xenotransplantation. Transplantation. 61: 989-96. PMID 8623205 DOI: 10.1097/00007890-199604150-00001 |
0.446 |
|
| 1996 |
Ellexson M, Lau M, Terasaki P, Hildebrand W. Characterization of an elusive HLA-A*6803 allele Human Immunology. 47: 116. DOI: 10.1016/0198-8859(96)85325-0 |
0.427 |
|
| 1996 |
Zhang L, Ellexson M, Chrétien P, Confer D, Hildebrand W. Sequence based detection of HLA class I mismatches for bone marrow transplantation Human Immunology. 47: 80. DOI: 10.1016/0198-8859(96)85127-5 |
0.334 |
|
| 1995 |
Ellexson ME, Zhang G, Stewart D, Lau M, Teresi G, Terasaki P, Roe B, Hildebrand W. Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant alpha-helical motifs produce complex serologic recognition patterns for the HLA-B"DT" and HLA-B"NM5" antigens. Human Immunology. 44: 103-10. PMID 8847228 DOI: 10.1016/0198-8859(95)00082-F |
0.422 |
|
| 1994 |
Hildebrand WH, Domena JD, Shen SY, Marsh SG, Bunce M, Guttridge MG, Darke C, Parham P. The HLA-B7Qui antigen is encoded by a new subtype of HLA-B27 (B*2708) Tissue Antigens. 44: 47-51. PMID 7974468 DOI: 10.1111/J.1399-0039.1994.Tb02356.X |
0.439 |
|
| 1994 |
Parham P, Arnett KL, Adams EJ, Barber LD, Domena JD, Stewart D, Hildebrand WH, Little AM. The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles. Tissue Antigens. 43: 302-13. PMID 7524186 DOI: 10.1111/J.1399-0039.1994.Tb02344.X |
0.378 |
|
| 1994 |
Hildebrand WH, Domena JD, Shen SY, Lau M, Terasaki PI, Bunce M, Marsh SGE, Guttridge MG, Bias WB, Parham P. HLA-B15: A widespread and diverse family of HLA-B alleles Tissue Antigens. 43: 209-218. PMID 7521976 DOI: 10.1111/J.1399-0039.1994.Tb02327.X |
0.358 |
|
| 1994 |
Little AM, Domena JD, Hildebrand WH, Shen SY, Barber LD, Marsh SGE, Bias WB, Parham P. HLA-B67: A member of the HLA-:B16 family that expresses the ME1 epitope Tissue Antigens. 43: 38-43. PMID 7517584 DOI: 10.1111/J.1399-0039.1994.Tb02294.X |
0.399 |
|
| 1994 |
Hildebrand W, Ellexson M, Stewart D, Lau M, Terasaki P, Teresi G. Conserved sequence motifs in the alpha helices of the serological variants HLA-B “DT” and HLA-B “NM5” Human Immunology. 40: 69. DOI: 10.1016/0198-8859(94)91795-7 |
0.389 |
|
| 1993 |
Madrigal JA, Hildebrand WH, Belich MP, Benjamin RJ, Little AM, Zemmour J, Ennis PD, Ward FE, Petzl-Erler ML, du Toit ED. Structural diversity in the HLA-A10 family of alleles: correlations with serology. Tissue Antigens. 41: 72-80. PMID 8475492 DOI: 10.1111/J.1399-0039.1993.Tb01982.X |
0.302 |
|
| 1993 |
Hildebrand WH, Domena JD, Parham P. Primary structure shows HLA-B59 to be a hybrid of HLA-B55 and HLA-B51, and not a subtype of HLA-B8 Tissue Antigens. 41: 190-195. PMID 8362411 DOI: 10.1111/J.1399-0039.1993.Tb02001.X |
0.407 |
|
| 1993 |
Domena JD, Hildebrand WH, Bias WB, Parham P. A sixth family of HLA-A alleles defined by HLA-A(*)8001 Tissue Antigens. 42: 156-159. PMID 8284791 DOI: 10.1111/J.1399-0039.1993.Tb02186.X |
0.408 |
|
| 1993 |
Domena JD, Little AM, Madrigal AJ, Hildebrand WH, Johnston-Dow L, Du Toit E, Bias WB, Parham P. Structural heterogeneity in HLA-B70, a high-frequency antigen of black populations Tissue Antigens. 42: 509-517. PMID 8146861 |
0.335 |
|
| 1992 |
Hildebrand WH, Madrigal JA, Little AM, Parham P. HLA-Bw22: A family of molecules with identity to HLA-B7 in the α1-helix Journal of Immunology. 148: 1155-1162. PMID 1737933 |
0.36 |
|
| 1992 |
Kawaguchi G, Hildebrand WH, Hiraiwa M, Karaki S, Nagao T, Akiyama N, Uchida H, Kashiwase K, Akaza T, Williams RC, Juji T, Parham P, Takiguchi M. Two subtypes of HLA-B51 differing by substitution at position 171 of the α2 helix Immunogenetics. 37: 57-63. PMID 1428012 DOI: 10.1007/Bf00223545 |
0.428 |
|
| 1992 |
Zemmour J, Gumperz JE, Hildebrand WH, Ward FE, Marsh SGE, Williams RC, Parham P. The molecular basis for reactivity of anti-Cw1 and anti-Cw3 alloantisera with HLA-B46 haplotypes Tissue Antigens. 39: 249-257. PMID 1384166 DOI: 10.1111/J.1399-0039.1992.Tb01943.X |
0.437 |
|
| 1992 |
Belich MP, Madrigal JA, Hildebrand WH, Zemmour J, Williams RC, Luz R, Petzl-Erler ML, Parham P. Unusual HLA-B alleles in two tribes of Brazilian Indians Nature. 357: 326-329. PMID 1317015 DOI: 10.1038/357326A0 |
0.413 |
|
| 1991 |
Madrigal JA, Belich MP, Benjamin RJ, Little AM, Hildebrand WH, Mann DL, Parham P. Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells. The Journal of Experimental Medicine. 174: 1085-95. PMID 1940790 DOI: 10.1084/Jem.174.5.1085 |
0.519 |
|
| Show low-probability matches. |